The recent development of methods to quantify NfL in serum has led to several reports on sNfL in neurodegenerative disorders and traumatic brain injury [4–6] and opens the door for large studies on NfL as a marker of neuronal damage also in diseases where lumbar puncture is not part of the clinical routine, such as stroke. This evidence concerns the gene NEFL and stroke disorder.